Women's Bodies, Women's Wisdom (188 page)

18
. Mantak Chia and Maneewan Chia,
Cultivating Female Sexual Energy: Healing
Love Through the Tao
(Huntington, NY: Healing Tao Books, 1986); available from Healing Tao Books, at
www.healingtao.com/b06.html
.

19
. Women’s sense of smell is more acute than men’s. A smell can evoke an entire stream of memories, either positive or negative. Smell is the longest-remembered sense. A particular smell evokes associated memories more than the senses of vision, hearing, and touch. The olfactory center is located in the brain in an area that is intimately connected with memory function.

20
. Part of normal dolphin life is being sexual with each other. A male dolphin often wraps his penis around a female’s lower body playfully—not to procreate but simply to communicate. Male dolphins sometimes do this when they are communicating with humans, too. This happened to my sister once—she described her dolphin encounter as an ecstatic experience.

21
. Riane Eisler,
Sacred Pleasure: Sex, Myth, and the Politics of the Body
(HarperSan-Francisco, 1995), p. 15.

22
. National Geographic Channel, “Totally Wild,” May 25, 2005.

23
. W. Cutler and E. Genovese-Stone, “Wellness in Women After 40 Years of Age: The Role of Sex Hormones and Pheromones,”
Disease-A-Month,
vol. 44, no. 9 (September 1998), p. 526.

24
. Antonio Damasio, “Brain Trust,”
Nature,
vol. 435 (June 2, 2005), pp. 571–72.

25
. S. R. Davis et al., “Testosterone for Low Libido in Postmenopausal Women Not Taking Estrogen,”
New England Journal of Medicine,
vol. 359, no. 19 (November 6, 2008), pp. 2005–17.

26
. Bud Berkeley,
Foreskin: A Closer Look
(Boston: Alyson Publications, 1993), p. 188.

27
. Josephine Lowndes Sevely,
Eve’s Secrets: A New Theory of Female Sexuality
(New York: Random House, 1987), p. 17; William H. Masters and Virginia E. Johnson,
Human Sexual Response
(Boston: Little, Brown, 1966), p. 46.

28
. K. O’Hara and J. O’Hara, “The Effect of Male Circumcision on the Sexual Enjoyment of the Female Partner,”
British Journal of Urology,
vol. 83, supplement 1 (Jan. 1999), pp. 79–84.

29
. Barbara Walker points out that the Hebrew Gospels designated Mary by the word
mah,
mistakenly translated as “virgin” but really meaning “young woman.” See also Esther Harding,
Women’s Mysteries, Ancient and Modern
(New York: Rider and Co., 1955).

Chapter 9

1
. See the book by the Body Shop Team,
Mamamoto: A Celebration
(New York: Viking, 1992), p. 78.

2
. T. R. Nansel et al., “The Association of Psychosocial Stress and Bacterial Vagi-nosis in a Longitudinal Cohort,”
American Journal of Obstetrics and Gynecology,
vol. 194, no. 2 (Feb. 2006), pp. 381–86.

3
. R. J. Hafner, S. L. Stanton, and J. Guy, “A Psychiatric Study of Women with Urgency and Urge Incontinence,”
British Journal of Urology,
vol. 49 (1977), pp. 211–14; L. R. Staub, H. S. Ripley, and S. Wolf, “Disturbance of Bladder Function Associated with Emotional States,”
Journal of the American Medical Association,
vol. 141 (1949), p. 1139.

4
. A. J. Macaulay et al., “Psychological Aspects of 211 Female Patients Attending a Urodynamic Unit,”
Journal of Psychosomatic Research,
vol. 31, no. 1 (1991), pp. 1–10; D. L. P. Rees and N. Farhoumand, “Psychiatric Aspects of Recurrent Cystitis in Women,”
British Journal of Urology,
vol. 49 (1977), pp. 651–58.

5
. M. Tarlau and M. A. Smalheiser, “Personality Patterns in Patients with Malignant Tumors of the Breast and Cervix,”
Psychosomatic Medicine,
vol. 13 (1951), p. 117. Women with cervical cancer characteristically experienced an early rejection; the patients grew up in homes lacking a male figure due to the death or desertion of the father.

6
. James H. Stephenson and William Grace, “Life Stress and Cancer of the Cervix,”
Psychosomatic Medicine,
vol. 14, no. 4 (1954), pp. 287–94.

7
. A. Schmale and H. Iker, “Psychological Setting of Uterine Cervical Cancer,”
Annals
of the New York Academy of Sciences,
vol. 125 (1966), pp. 807–13.

8
. M. H. Antoni and K. Goodkin, “Host Moderator Variables in the Promotion of Cervical Neoplasia: I. Personality Facets,”
Journal of Psychosomatic Research,
vol. 32, no. 3 (1988), pp. 327–28.

9
. K. Goodkin et al., “Stress and Hopelessness in the Promotion of Cervical Intraneo-plasia to Invasive Squamous Cell Carcinoma of the Cervix,”
Journal of Psychosomatic
Research,
vol. 30, no. 1 (1986), pp. 67–76.

10
. J. Buscema, “The Predominance of Human Papilloma Virus—Type 16 in Vulvar Neoplasia,”
Obstetrics and Gynecology,
vol. 71, no. 4 (1988), pp. 601–5.

11
. The American Society for Colposcopy and Cervical Pathology, “Descriptions of the New FDA-Approved HPV DNA Tests,”
HPV Genotyping Clinical Update
(2009); available online at
www.omniaeducation.com/ iig/IIG_Addenda/Clinical_ Update_2009.pdf
.

12
. R. Kiecolt-Glaser, J. K. Glaser, C. E. Speicher, and J. E. Holliday, “Stress, Loneliness, and Changes in Herpes Virus Latency,”
Journal of Behavioral Medicine,
vol. 8, no. 3 (1985), pp. 249–60.

13
. Two studies note that many patients have effectively used hypnosis to relieve warts. See R. H. Rulison, “Warts: A Statistical Study of 921 Cases,”
Archives of
Dermatology and Syphilology,
vol. 46 (1942), pp. 66–81; and M. Ullman, “On the Psyche and Warts. II: Hypnotic Suggestion and Warts,”
Psychosomatic Medicine,
vol. 22 (1960), pp. 68–76.

14
. To diagnose warts that aren’t visible, or so-called flat warts, the penis must be bathed in vinegar and then viewed through some sort of magnifying lens. Only then will the flat white warts be obvious to those who know what to look for. Treatment issues for men are exactly the same as for women.

15
. For more information about podofilox,
visit.www.watson.com
.

16
. L. Sadler, A. Saftlas, W. Wang, M. Exeter, J. Whittaker, L. McCowan, “Treatment for Cervical Intraepithelial Neoplasia and Risk of Preterm Delivery,”
Journal of
the American Medical Association,
vol. 291, no. 17 (May 5, 2004), pp. 2100–6.

17
. N. Whitehead et al., “Megaloblastic Changes in Cervical Epithelium: Association of Oral Contraceptive Therapy and Reversal with Folic Acid,”
Journal of the
American Medical Association,
vol. 226 (1993), pp. 1421–24; J. N. Orr, “Localized Deficiency of Folic Acid in Cervical Epithelial Cells May Promote Cervical Dysplasia and Eventually Carcinoma of the Cervix,”
American Journal of Obstetrics
and Gynecology,
vol. 151 (1985), pp. 632–35; J. Lindenbaum et al., “Oral Contraceptive Hormones, Eolate Metabolism, and Cervical Epithelium,”
American
Journal of Clinical Nutrition,
Apr. 1975, pp. 346–53; S. L. Romney et al., “Plasma Vitamin C and Uterine Cervical Dysplasia,”
American Journal of Obstetrics
and Gynecology,
vol. 151, no. 7 (1985), pp. 976–80; S. L. Romney et al., “Retinoids in the Prevention of Cervical Dysplasia,”
American Journal of Obstetrics
and Gynecology,
vol. 141, no. 8 (1981), pp. 890–94; S. Wassertheil-Smaller et al., “Dietary Vitamin C and Uterine Cervical Dysplasia,”
American Journal of
Epidemiology,
vol. 114, no. 5 (1981), pp. 714–24; C. LaVecchia et al., “Dietary Vitamin A and the Risk of Invasive Cervical Cancer,”
International Journal of
Cancer,
vol. 34 (1985), pp. 319–22; P. Ramsnamy and R. Natarajan, “Vitamin B6 Status in Patients with Cancer of the Uterine Cervix,”
Nutrition and Cancer,
vol. 6 (1984), pp. 176–80; E. Dawson et al., “Serum Vitamin and Selenium Changes in Cervical Dysplasia,”
Federal Proceedings,
vol. 43 (1984), p. 612.

18
. Louise Hay,
I Love My Body
(Farmingdale, NY: Coleman Publishing, 1985), p. 49.

19
. A. Gandey, “Report of Motor Neuron Disease After HPV Vaccine,”
Medscape
(October 28, 2009); available online at
www.medscape.com/viewarticle/711461
.

20
. Ibid.

21
. I. Sutton et al., “CNS Demyelination and Quadrivalent HPV Vaccination,”
Multiple
Sclerosis,
vol. 15, no. 1 (January 2009), pp. 116–19.

22
. B. A. Slade et al., “Postlicensure Safety Surveillance for Quadrivalent Human Pa-pillomavirus Recombinant Vaccine,”
Journal of the American Medical Association,
vol. 302, no. 7 (August 19, 2009), pp. 750–57.

23
. “Death After Cervarix Propels HPV Vaccination into Headlines Again,”
Med-scape
(September 30, 2009; updated October 1, 2009); available online at
www.medscape.com/viewarticle/709718
.

24
. L. Gavin et al., “Sexual and Reproductive Health of Persons Aged 10–24 Years— United States, 2002–2007,”
Morbidity and Mortality Weekly Report,
vol. 58, no. SS-6 (July 17, 2009), pp. 1–58.

25
. C. Young, in a letter written to
Obstetrics and Gynecology,
the professional journal of the American College of Obstetricians and Gynecologists; published online April 5, 2008, by
VaccineInfo.net
and available at
http://www.vaccineinfo.net/ immunization/vaccine/hpv/doc_against_HPV.shtml
.

26
. M. A. Steller and T. E. Nolan, “Universal Human Papillomavirus Vaccination: Pro and Con,”
The Female Patient,
vol. 32, no. 5 (May 2007), pp. 47–48.

27
. K. Hikel, “ ‘One Less’ Sucker,” Green Mountain Doc, Medscape blog (February 16, 2009), available online at
http://boards.medscape.com/ forums?128@1005 [email protected]!comment=1
.

28
. R. L. Winer et al., “Condom Use and the Risk of Genital Human Papillomavirus Infection in Young Women,”
New England Journal of Medicine,
vol. 354, no. 25 (June 22, 2006), pp. 2645–54.

29
. D.T. Fleming, G. M. McQuillian, R. E. Johnson, et al., “Herpes Simplex Virus Type 2 in the United States, 1976 to 1994,”
New England Journal of Medicine,
vol. 337, no. 16 (1997), pp. 1105–11.

30
. G. J. Mertz, S. L. Rosenthal, and L. R. Stanberry, “Is Herpes Simplex Virus Type 1 (HSV-1) Now More Common than HSV-2 in First Episodes of Genital Herpes?”
Sexually Transmitted Diseases,
vol. 30, no. 10 (Oct. 2003), pp. 801–2; A. Wald et al., “Oral Shedding of Herpes Simplex Virus Type 2,”
Sexually Transmitted Infections,
vol. 80, no. 4 (Aug. 2004), pp. 272–76 [published erratum appears in
Sexually
Transmitted Infections,
vol. 80, no. 6 (Dec. 2004), p. 546]; R. Engelberg et al., “Natural History of Genital Herpes Simplex Virus Type 1 Infection,”
Sexually
Transmitted Diseases,
vol. 30, no. 2 (Feb. 2003), pp. 174–77.

31
. A. Wald et al., “Frequent Genital Herpes Simplex Virus 2 Shedding in Immuno-competent Women: Effect of Acyclovir Treatment,”
Journal of Clinical Investigation,
vol. 99, no. 5 (March 1997), pp. 1092–97.

32
. Ibid.

33
. L. Koutsky et al., “Underdiagnosis of Genital Herpes by Current Clinical and Viral-Isolation Procedures,”
New England Journal of Medicine,
vol. 326, no. 23 (1992), pp. 1533–39.

34
. H. C. Taylor, “Vascular Congestion and Hyperemia,”
American Journal of Obstetrics
and Gynecology,
vol. 57, no. 22 (1949), p. 22; M. E. Kemeny et al., “Psychological and Immunological Predictors of Genital Herpes Recurrence,”
Psychosomatic Medicine,
vol. 52 (1989), p. 195–208.

35
. A. Wald et al., “Reactivation of Genital Herpes Simplex Virus Type 2 Infection in Asymptomatic Seropositive Persons,”
New England Journal of Medicine,
vol. 342, no. 12 (March 23, 2000), pp. 844–50.

36
. Z. A. Brown et al., “Genital Herpes Complicating Pregnancy,”
Obstetrics and Gynecology,
vol. 106, no. 4 (October 2005), pp. 845–56.

37
. K. M. Stone et al., “Pregnancy Outcomes Following Systemic Prenatal Acyclovir Exposure: Conclusions from the International Acyclovir Pregnancy Registry, 1984–1999,”
Birth Defects Research Part A, Clinical and Molecular Teratology,
vol. 70, no. 4 (April 2004), pp. 201–7.

38
. Z. A. Brown et al., “Effect of Serologic Status and Cesarean Delivery on Transmission Rates of Herpes Simplex Virus from Mother to Infant,”
Journal of the American
Medical Association,
vol. 289, no. 2 (Jan. 8, 2003), pp. 203–9.